Atlas Trials

Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)

Clinical trial NCT00782184 · COMPLETED

Trial details

NCT number
NCT00782184
Sponsor
Organon and Co
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypercholesterolemia
Start date
2008-11-01
Primary completion
2010-09-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.